Assessment of the Diagnostic and Prognostic Values of CD200 and CD43 in CLL and Leukemic Phase of NHL
BACKGROUND: Chronic lymphoproliferative disorders (LPDs), such as chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL), are comprised heterogeneous malignant hematopoietic clinicopathologic syndromes with broad clinical features. Molecular diagnostic procedures such as immunophenotyping...
Saved in:
Main Authors: | Teeb M. Jaafar Al-Khafaji, Ahmed Ibraheem Rashid |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Journal of Applied Hematology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/joah.joah_103_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma
by: Dan Zhu, et al.
Published: (2024-12-01) -
CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibody
by: Cristina Melero, et al.
Published: (2024-12-01) -
Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysis
by: Fanqiao Meng, et al.
Published: (2025-01-01) -
Upregulation of CD19 by low‐dose chidamide promotes CAR T cells functionality in B-cell non-Hodgkin lymphoma
by: Ying Ni, et al.
Published: (2025-01-01) -
Illuminating the impact of CD38-induced adenosine formation in B-cell lymphoma
by: Shams ElDoha Galal ElDin Zaiema, et al.
Published: (2025-01-01)